Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Incidence of Second Primary Malignancies and Association with Treatment in US Veterans with Multiple Myeloma

Nathanael Fillmore, PhD, Sarvari Venkata Yellapragada, MD, Cenk Yildirim, MS, Aimaz Afrough, MD, Adanma Anji Ayanambakkam Attanathi, MD, Ifeorah Chizoba, MPH, Nhan Do, MD, Mary Brophy, MD MPH, Nikhil C. Munshi, MD

Blood (2019) 134 (Supplement_1): 1806.

https://doi.org/10.1182/blood-2019-132227

Published: 2019

Journal Articles

Measurement of Serum microRNAs in US Veterans with Monoclonal Gammopathy of Undetermined Significance

Weixin Wang, PhD, Youn K Shim, PhD, Joel E Michalek, PhD, Emily Barber, BS, Layla M Saleh, MD PhD, Byeong Yeob Choi, PhD, Chen-Pin Wang, PhD, Norma Ketchum, MS, Rene Costello, MT, Gerald E Marti, MD PhD, Robert Vogt, PhD, Ola Landgren, MD PhD, Katherine R. Calvo, MD PhD

Blood (2018) 132 (Supplement 1): 5576.

https://doi.org/10.1182/blood-2018-99-114821

Published: 2018

Journal Articles

Incidence of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Subsequent Transformation to Multiple Myeloma (MM) and Effect of Exposure to Agent Orange (AO) : A Single Center Experience from VA Detroit

Naresh Bumma, MD, Misako Nagasaka, MD, Seongho Kim, PhD, Hema M. Vankayala, MD, Shabbir Ahmed, MD, Pallavi Jasti, MD

Blood (2017) 130 (Supplement 1): 5383.

https://doi.org/10.1182/blood.V130.Suppl_1.5383.5383

Published: 2017

Journal Articles

Agent Orange Exposure Does Not Predict for Shorter Overall Survival in Patients with Chronic Lymphocytic Leukemia: A National Veteran Affairs Tumor Registry Study

Craig Mescher, MD, Nicole Randall, MD, Gobind Tarchand, Lisa M. Baumann Kreuziger, MD MS, Dave Gilbertson, Julie Tomaska, Vicki A. Morrison, MD

Blood (2016) 128 (22): 5568.

https://doi.org/10.1182/blood.V128.22.5568.5568

Published: 2016

Journal Articles

Previous Agent Orange Exposure Is Correlated with Worse Outcome in Patients with Multiple Myeloma (MM)

Natalie Scott Callander, MD, Cesar O. Freytes, MD, Suhong Luo, MPH, Kenneth R Carson, MD PhD

Blood (2015) 126 (23): 4194.

https://doi.org/10.1182/blood.V126.23.4194.4194

Published: 2015

Journal Articles

A Case-Control Epidemiological Study Of Waldenstrom Macroglobulinemia

Yosra Aljawai, MS, Serena McDiarmid, Joseph Cappuccio, Federico Campigotto, MS, Steven Peter Treon, MD, MA, PhD, Edie A. Weller, PhD, Brenda M. Birmann, ScD, Irene M Ghobrial, MD

Blood (2013) 122 (21): 1713.

https://doi.org/10.1182/blood.V122.21.1713.1713

Published: 2013

Journal Articles

The Impact of Agent Orange Exposure On Presentation and Prognosis of Patients with Chronic Lymphocytic Leukemia (CLL): An Exploratory Analysis

Lisa M Baumann Kreuziger, MD, Vicki A. Morrison, MD

Blood (2012) 120 (21): 4575.

https://doi.org/10.1182/blood.V120.21.4575.4575

Published: 2012

Journal Articles

Military Service in Vietnam/Korea and Serum Dioxin Levels Do Not Affect the Outcomes of Patients Diagnosed with Plasma Cell Dyscrasias

Prasanth Ganesan, MD, Emil Kuriakose, MD, Carla Smith, Robert T Harris, Jonathan E Dowell, MD, Arnold Schecter, Simrit Parmar, M.D.

Blood (2011) 118 (21): 5098.

https://doi.org/10.1182/blood.V118.21.5098.5098

Published: 2011

Journal Articles

Racial Disparities in Diffuse Large B Cell Lymphoma: A VA Population Study.

Sanjay Maraboyina, Rami S. Komrokji, Rami Y. Haddad, Zeina A. Nahleh, Malek M. Safa

Blood (2006) 108 (11): 4614.

https://doi.org/10.1182/blood.V108.11.4614.4614

Published: 2006

Journal Articles

Chronic Hepatitis C Infection and Hematologic Malignancies: Is There an Association?.

Peter A. Boehringer, MD, Ming C. Kuan, MD, Michael W. Peterson, MD

Blood (2005) 106 (11): 2829.

https://doi.org/10.1182/blood.V106.11.2829.2829

Published: 2005

Journal Articles

Chronic Inflammation May Predispose to the Development of Plasma Cell Dyscrasias.

Elizabeth M. Blanchard, MD, Elizabeth Lawler, MPH, Mary Brophy, MD, MPH, Louis Fiore, MD, MPH, Nikhil C. Munshi, MD

Blood (2004) 104 (11): 3650.

https://doi.org/10.1182/blood.V104.11.3650.3650

Published: 2004

NARROW

Incidence of Second Primary Malignancies and Association with Treatment in US Veterans with Multiple Myeloma

Measurement of Serum microRNAs in US Veterans with Monoclonal Gammopathy of Undetermined Significance

Incidence of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Subsequent Transformation to Multiple Myeloma (MM) and Effect of Exposure to Agent Orange (AO) : A Single Center Experience from VA Detroit

Agent Orange Exposure Does Not Predict for Shorter Overall Survival in Patients with Chronic Lymphocytic Leukemia: A National Veteran Affairs Tumor Registry Study

Previous Agent Orange Exposure Is Correlated with Worse Outcome in Patients with Multiple Myeloma (MM)

A Case-Control Epidemiological Study Of Waldenstrom Macroglobulinemia

The Impact of Agent Orange Exposure On Presentation and Prognosis of Patients with Chronic Lymphocytic Leukemia (CLL): An Exploratory Analysis

Military Service in Vietnam/Korea and Serum Dioxin Levels Do Not Affect the Outcomes of Patients Diagnosed with Plasma Cell Dyscrasias

Racial Disparities in Diffuse Large B Cell Lymphoma: A VA Population Study.

Chronic Hepatitis C Infection and Hematologic Malignancies: Is There an Association?.

Chronic Inflammation May Predispose to the Development of Plasma Cell Dyscrasias.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only